Grants and Contributions

•The CIHR HIV/AIDS Research Initiative, managed by the CIHR Institute of Infection and Immunity (III), and responsible for the management and oversight of the research components of the Federal Initiative to Address HIV/AIDS in Canada, will provide funding for applications that have a primary focus on HIV/AIDS and/or any other STBBI (as identified in the Public Health Agency of Canada’s pan-Canadian STBBI framework for action) across all CIHR Research Themes (i.e., biomedical research, clinical research, health services research and social, cultural, environmental and population health research).

The specific objectives of this funding opportunity are:

-Accelerate the availability of high-quality and real-time evidence to support Canada’s rapid response to the global pandemic in order to better prevent, detect, treat and manage COVID-19;
-Test, and study the implementation of interventions to treat and manage COVID-19 by amplifying the WHO Solidarity trial in Canada;
-Enable Canadian engagement and coordination in international large-scale trials and better enable harmonized data collection, sharing of data, rapid large-scale evaluation of impact;
-Provide evidence to inform clinical and health system management and public health response, and/or decision-making and planning within and across jurisdictions in Canada and internationally; and
-Enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

The specific objectives of this funding opportunity are to:

Enable the development and dissemination of national guidelines related to prescribing, dispensing, and delivery of opioids and other narcotics during the COVID-19 pandemic to support people who use drugs (PWUD)
Identify opportunities to facilitate or improve individuals who use substances' access to medication during the pandemic, including OAT
Describe challenges faced by PWUD in relation to the pandemic, by directly engaging with PWUD and hearing their voices
Identify changes in drug use patterns and impacts during the pandemic
Assess the impacts of health interventions to support PWUD in relation to the pandemic and recommend which services should be retained post pandemic and/or integrated into future emergency response plans
Provide evidence to inform clinical and health system management and public health responses related to substance use, and/or decision-making and planning within and across jurisdictions in Canada

•The CIHR HIV/AIDS Research Initiative, managed by the CIHR Institute of Infection and Immunity (III), and responsible for the management and oversight of the research components of the Federal Initiative to Address HIV/AIDS in Canada, will provide funding for applications that have a primary focus on HIV/AIDS and/or any other STBBI (as identified in the Public Health Agency of Canada’s pan-Canadian STBBI framework for action) across all CIHR Research Themes (i.e., biomedical research, clinical research, health services research and social, cultural, environmental and population health research).

•The CIHR HIV/AIDS Research Initiative, managed by the CIHR Institute of Infection and Immunity (III), and responsible for the management and oversight of the research components of the Federal Initiative to Address HIV/AIDS in Canada, will provide funding for applications that have a primary focus on HIV/AIDS and/or any other STBBI (as identified in the Public Health Agency of Canada’s pan-Canadian STBBI framework for action) across all CIHR Research Themes (i.e., biomedical research, clinical research, health services research and social, cultural, environmental and population health research).

To support the growing number of brain health practitioners providing assessments via telehealth, this project will i) improve the administration of remote assessments and ii) expand the variety and clinical value of data collected.

It is anticipated that the test could be used for multiple purposes, including for serosurveillance of populations or as an aid in diagnosis of SARS-CoV2 infection in conjunction with clinical presentation and the results of other tests.

​The objective of this project is for the intern to gain experience in a veterinary clinic, through assisting in production medicine, cleanliness of clinic and workspace, care and cleanliness of animals under our care, sanitation and sterilization of equipment.

This project will develop a lead candidate anti-CD22 CAR (Chimeric Antigen Receptor) comprising a camelid antibody derived anti-CD22 binding domain (developed by NRC) in the context of a CAR backbone and lentiviral vector system (developed by BC Cancer), suitable for inclusion in a CTA (Clinical Trial Application) submission to Health Canada

Even individuals who show substantial clinical improvement continue to demonstrate impairments in workplace functioning compared to neverdepressed individuals (Adler et al., 2006).